<DOC>
<DOCNO>
EP-0007751
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C12P-1/04 C12R-1/39 C07H-7/00 <main>C07H-7/02</main> C12P-7/60 C12P-7/40 C07H-7/027 
</IPC-CLASSIFICATIONS>
<TITLE>
destruction by fermentation of 2-ketogluconate in the presence of 2-ketogulonate.
</TITLE>
<APPLICANT>
pfizerus<sep>pfizer inc.<sep>pfizer inc.235 east 42nd streetnew york, n.y. 10017us<sep>pfizer inc.<sep>
</APPLICANT>
<INVENTOR>
fenton dennis michael<sep>gagne john william<sep>kita donald albert<sep>fenton, dennis michael<sep>gagne, john william<sep>kita, donald albert<sep>fenton, dennis michael864 long cove roadgales ferry, new london connecticutus<sep>gagne, john williampinebrook villagenorwich, new london connecticutus<sep>kita, donald albertmeadowwood roadessex, new london connecticutus<sep>fenton, dennis michael <sep>gagne, john william<sep>kita, donald albert  <sep>fenton, dennis michael 864 long cove roadgales ferry, new london connecticutus<sep>gagne, john williampinebrook villagenorwich, new london connecticutus<sep>kita, donald albertmeadowwood roadessex, new london connecticutus<sep>
</INVENTOR>
<ABSTRACT>
2-ketogluconate present in a mixture with  2-ketogulonate is destroyed by fermentation with a strain of  pseudomonas fluorescens leaving desired 2-ketogulonate  intact.  subsequent hydrolysis of the 2-ketogulonate yields  ascorbic acid.  the preferred pseudomonas strains are nrrl  b10 and atcc 13430.  
</ABSTRACT>
</TEXT>
</DOC>
